Acute kidney injury in pregnancy: A clinical challenge

Journal of Nephrology

Volumn 25, Issue 1, 2012, Pages 19-30

  Machado, Susana ^a   Figueiredo, Nuno ^a   Borges, Andreia ^a   Pais, Maria São José ^b   Freitas, Luís ^a   Moura, Paulo ^b   Campos, Mário ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b Daniel de Matos Maternity Hospital   (Portugal)

Author keywords

Acute kidney injury; Preeclampsia; Pregnancy complications; Thrombotic microangiopathies

Indexed keywords

FRESH FROZEN PLASMA; LABETALOL; METHYLDOPA;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; CLINICAL FEATURE; CREATININE CLEARANCE; CRYOPRECIPITATE; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; FETUS OUTCOME; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HELLP SYNDROME; HEMODIALYSIS; HIGH RISK PREGNANCY; HUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PLASMAPHERESIS; PREECLAMPSIA; PREGNANCY OUTCOME; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; URINALYSIS; FEMALE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ACUTE KIDNEY INJURY; FATTY LIVER; FEMALE; HELLP SYNDROME; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOTIC MICROANGIOPATHIES;

EID: 84862274452     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000013     Document Type: Review

References (99)

1. Gammill HS, Jeyabalan A. Acute renal failure in pregnancy. Crit Care Med. 2005;33(10)(Suppl):S372-S384.
2. Rasmussen PE, Nielsen FR. Hydronephrosis during pregnancy: a literature survey. Eur J Obstet Gynecol Reprod Biol. 1988;27(3):249-259.
3. Krane NK, Hamrahian M. Pregnancy: kidney diseases and hypertension. Am J Kidney Dis. 2007;49(2):336-345.
4. Danielson LA, Kercher LJ, Conrad KP. Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats. Am J Physiol Regul Integr Comp Physiol. 2000;279(4):R1298-R1304.
5. Fekete A, Sasser JM, Baylis C. Chronic vasodilation produces plasma volume expansion and hemodilution in rats: consequences of decreased effective arterial blood volume. Am J Physiol Renal Physiol. 2011;300(1):F113-F118.
6. Conrad KP, Lindheimer M. Renal and cardiovascular alterations. In: Lindheimer M, Roberts J, Cunningham F, eds. Chesley's hypertensive disorders in pregnancy. 3rd ed. Amsterdam: Elsevier. 2009:297-334.
7. Jeyabalan A, Conrad KP. Renal function during normal pregnancy and preeclampsia. Front Biosci. 2007;12(1):2425-2437.
8. August P. The patient with kidney disease and hypertension in pregnancy. In: Schrier RW, ed. Manual of nephrology. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2009:220-243.
9. Zhu Y, Goff JP, Reinhardt TA, Horst RL. Pregnancy and lactation increase vitamin D-dependent intestinal membrane calcium adenosine triphosphatase and calcium binding protein messenger ribonucleic acid expression. Endocrinology. 1998;139(8):3520-3524.
10. August P. The kidney in pregnancy. In: Greenberg A, Cheung A, Falk R, Coffman T, Jeannette J, eds. Primer on kidney diseases. 4th ed. National Kidney Foundation;National Kidney Foundation; Philadephia, PA. 2005:426-435.
11. Piccoli GB, Conijn A, Attini R, et al. Pregnancy in chronic kidney disease: need for a common language. J Nephrol. 2011;24(3):282-299.
12. Lafayette R. AKI in pregnant patient: two lives at stake. Nephrology Times. 2010;3(5):9-10.
13. Smith MC, Moran P, Ward MK, Davison JM. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG. 2008;115(1):109-112.
14. Alper AB, Yi Y, Webber LS, et al. Estimation of glomerular filtration rate in preeclamptic patients. Am J Perinatol. 2007;24(10):569-574.
15. Rodriguez-Thompson D, Lieberman ES. Use of a random urinary protein-to-creatinine ratio for the diagnosis of significant proteinuria during pregnancy. Am J Obstet Gynecol. 2001;185(4):808-811.
16. Maynard SE, Thadhani R. Pregnancy and the kidney. J Am Soc Nephrol. 2009;20(1):14-22.
17. Chan P, Brown M, Simpson JM, Davis G. Proteinuria in preeclampsia: how much matters? BJOG. 2005;112(3):280-285.
18. Martins-Costa SH, Vettorazzi J, Valério E, et al. Protein creatinine ratio in random urine sample of hypertensive pregnant women: maternal and perinatal outcomes. Hypertens Pregnancy. 2011;30(3):331-337.
19. Prakash J, Niwas SS, Parekh A, et al. Acute kidney injury in late pregnancy in developing countries. Ren Fail. 2010;32(3):309-313.
20. Dragun K, Haase M. Acute kidney failure during pregnancy and postpartum. In: Jörres A, Ronco C, Kellum J, eds. Management of acute kidney problems. Springer; Berlin. 2010:445-458.
21. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785-799.
22. Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens. 2010;28(7):1349-1355.
23. Forbes K, Westwood M. Maternal growth factor regulation of human placental development and fetal growth. J Endocrinol. 2010;207(1):1-16.
24. Khankin EV, Royle C, Karumanchi SA. Placental vasculature in health and disease. Semin Thromb Hemost. 2010;36(3): 309-320.
25. Hu Y, Dutz JP, MacCalman CD, Yong P, Tan R, von Dadelszen P. Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: a role for IFN-γ. J Immunol. 2006; 177(12):8522-8530.
26. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631-644.
27. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Preeclampsia: a renal perspective. Kidney Int. 2005;67(6):2101-2113.
28. Yagel S. Angiogenesis in gestational vascular complications. Thromb Res. 2011;127(Suppl 3):S64-S66.
29. Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med. 2008;59(1):61-78.
30. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672-683.
31. Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am. 2010;37(2): 239-253.
32. Kita N, Mitsushita J. A possible placental factor for preeclampsia: sFlt-1. Curr Med Chem. 2008;15(7):711-715.
33. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12(6):642-649.
34. Chen Y. Novel angiogenic factors for predicting preeclampsia: sFlt-1, PIGF and soluble endoglin. Open Clinical Chemistry Journal. 2009;2:1-6.
35. Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia: a step forward but not the definitive answer. J Reprod Immunol. 2009;82(2):106-111.
36. Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv. 2005;60(12):807-816.
37. Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S. Immunology of preeclampsia. Chem Immunol Allergy. 2005;89:49-61.
38. Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta. 2008; 29(Suppl A):S73-S77
39. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response: a review. Placenta 2003;24(Suppl A):S21-S27.
40. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2008;78(1):93-100.
41. Paruk F, Moodley J. Maternal and neonatal outcome in early- and late-onset pre-eclampsia. Semin Neonatol. 2000; 5(3):197-207.
42. Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(2):133-137.
43. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52(5):873-880.
44. Koopmans CM, van Pampus MG, Groen H, Aarnoudse JG, van den Berg PP, Mol BW. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. Eur J Obstet Gynecol Reprod Biol. 2009;146(1):8-14.
45. Karumanchi S, Epstein F. Renal complications in pregnancy. In: Feehally J, Floege J, Johnson R, eds. Comprehensive clinical nephrology. 3rd ed. Mosby; Philadelphia, PA. 2007.
46. Turner JA. Diagnosis and management of pre-eclampsia: an update. Int J Womens Health. 2010;2:327-337.
47. Skjaerven R, Vatten LJ, Wilcox AJ, Rønning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ. 2005;331(7521):877.
48. Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010;140(3):365-371.
49. Jacquemyn Y, Zemtsova O. Risk factors and prediction of preeclampsia. Acta Clin Belg. 2010;65(1):1-12.
50. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008;112(2, Part 1) (2 Pt 1):359-372.
51. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010;(8):CD001059.
52. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA; PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369(9575):1791-1798.
53. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2):CD004659.
54. Hauth JC, Ewell MG, Levine RJ, et al; Calcium for Preeclampsia Prevention Study Group. Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstet Gynecol. 2000;95(1):24-28.
55. Bombrys AE, Barton JR, Nowacki EA, et al. Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol. 2008;199(3):247, e1-e6.
56. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010;122(6):579-584.
57. Terry MB, Perrin M, Salafia CM, et al. Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol. 2007;165(9):1007-1014.
58. Strobl I, Windbichler G, Strasak A, et al. Left ventricular function many years after recovery from pre-eclampsia. BJOG. 2011;118(1):76-83.
59. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103(5 Pt 1):981-991.
60. Barton JR, Sibai BM. Gastrointestinal complications of preeclampsia. Semin Perinatol. 2009;33(3):179-188.
61. Pan C, Perumalswami PV. Pregnancy-related liver diseases. Clin Liver Dis. 2011;15(1):199-208.
62. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet. 2010;375(9714):594-605.
63. Picinni P, Gallo G. Diagnosis and management of HELLP syndrome. In: Ronco C, Bellomo R, Kellum J, eds. Critical care nephrology. 2nd ed. Saunders; Philadelphia, PA. 2009:337-340.
64. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management: a Review. BMC Pregnancy Childbirth. 2009;9(1):8.
65. Baxter JK, Weinstein L. HELLP syndrome: the state of the art. Obstet Gynecol Surv. 2004;59(12):838-845.
66. Drakeley AJ, Le Roux PA, Anthony J, Penny J. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol. 2002;186(2):253-256.
67. Celik C, Gezginç K, Altintepe L, et al. Results of the pregnancies with HELLP syndrome. Ren Fail. 2003;25(4):613-618.
68. Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y. Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure. Ren Fail. 2004;26(5):557-562.
69. Knight M, Nelson-Piercy C, Kurinczuk JJ, Spark P, Brocklehurst P; UK Obstetric Surveillance System. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008;57(7):951-956.
70. Lee NM, Brady CW. Liver disease in pregnancy. World J Gastroenterol. 2009;15(8):897-906.
71. Guntupalli SR, Steingrub J. Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med. 2005;33(10)(Suppl):S332-S339.
72. Wei Q, Zhang L, Liu X. Clinical diagnosis and treatment of acute fatty liver of pregnancy: a literature review and 11 new cases. J Obstet Gynaecol Res. 2010;36(4):751-756.
73. Santana L, Hernández Medina E, O'Shanahan G, Sánchez-Palacios M. Acute renal failure in acute fatty liver of pregnancy: apropos of a case. Nefrologia. 2005;25(4): 453-454.
74. Koroshi A, Babameto A. Acute renal failure during acute fatty liver of pregnancy. Nephrol Dial Transplant. 2002;17(6):1110-1112.
75. Fesenmeier MF, Coppage KH, Lambers DS, Barton JR, Sibai BM. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005;192(5):1416-1419.
76. Ko H, Yoshida EM. Acute fatty liver of pregnancy. Can J Gastroenterol. 2006;20(1):25-30.
77. Westbrook RH, Yeoman AD, Joshi D, et al. Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transplant. 2010;10(11):2520-2526.
78. Matthews JH, Benjamin S, Gill DS, Smith NA. Pregnancy-associated thrombocytopenia: definition, incidence and natural history. Acta Haematol. 1990;84(1):24-29.
79. Fakhouri F, Frémeaux-Bacchi V. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura? Nat Clin Pract Nephrol. 2007;3(12):679-687.
80. George J. The thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: evaluation, management and long-term outcomes experience of the Oklahoma TTP-HUS registry, 1989-2007. Kidney Int. 2009;112:S52-S54.
81. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood. 2001;98(9): 2730-2735.
82. Vesely SK, George JN, Lämmle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102(1):60-68.
83. Besbas N, Karpman D, Landau D, et al; European Paediatric Research Group for HUS. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70(3): 423-431.
84. Fakhouri F, Roumenina L, Provot F, et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol. 2010;21(5): 859-867.
85. Martin JN Jr, Bailey AP, Rehberg JF, Owens MT, Keiser SD, May WL. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006. Am J Obstet Gynecol. 2008;199(2): 98-104.
86. George JN. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2003;10(5):339-344.
87. Ruggenenti P, Cravedi P, Remuzzi G. Thrombotic microangiopathies including hemolytic uremic syndrome. In: Floege J, Johnson R, Feehally J, eds. Comprehensive clinical nephrology. 4th ed. Mosby; Philadelphia, PA. 2010:344-355.
88. Laszik Z. Thrombotic microangiopathies. In: Silva F, D'Agati V, Nadasdy T, eds. Renal biopsy interpretation. Churchill Livingstone; Oklahoma. 1996.
89. Grünfeld JP, Pertuiset N. Acute renal failure in pregnancy: 1987. Am J Kidney Dis. 1987;9(4):359-362.
90. Jeong JY, Kim SH, Lee HJ, Sim JS. Atypical low-signal-intensity renal parenchyma: causes and patterns. Radiographics. 2002;22(4):833-846.
91. Brown M, Mangos G, Peek M, Plaat F. Renal disease in pregnancy. In: Powrin R, Greene M, Camman W, eds. De Swiet's medical disorders in obstetric practice. 5th ed. Wiley-Blackwell; Oxford. 2010.
92. Vidaeff AC, Carrol MA, Rami SM. Acute hypertensive emergencies in pregnancy. Crit Care Med 2005;33(10 Suppl):S307:S312
93. Souza AR, Amorim MR, Costa AA, Neto CN. Antihypertensive treatment in pregnancy. Acta Med Port 2010;23(1):77-84
94. Ganesan C, Maynard SE. Acute kidney injury in pregnancy: the thrombotic microangiopathies. J Nephrol. 2011; pii: DE59A637-F706-47BF-931E-A6857A01DB8A [ePub Jan14].
95. Anantharaman P, Schimdt R, Holley J. Pregnancy & renal diseases. In: Nissenson A, Berns J, Lerma E, eds. Current diagnosis and treatment: nephrology and hypertension, McGraw-Hill; International Edition. 2009:497-498.
96. Okundaye I, Abrinko P, Hou S. Registry of pregnancy in dialysis patients. Am J Kidney Dis. 1998;31(5):766-773.
97. Lindheimer M, Conrad K, Umans J. The normal and disease kidney in pregnancy. In: Schrier R, ed. Diseases of the kidney and urinary tract. Vol. 3; 8th ed. Philadelphia, PA: Lippincott Williams & Wilkinson; 2007:1933.
98. Magee LA, Yong PJ, Espinosa V, Côté AM, Chen I, von Dadelszen P. Expectant management of severe preeclampsia remote from term: a structured systematic review. Hypertens Pregnancy. 2009;28(3):312-347.
99. Gaugler-Senden IP, Huijssoon AG, Visser W, Steegers EA, de Groot CJ. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation: audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):216-221.